Clinical pathologic conference

Pyeritz RE. The Marfan syndrome. Annu Rev Med 2000; 51: 481-510.

Dean JC. Management of Marfan syndrome. Heart 2002; 88: 97-103.

Robinson PN , Booms P. The molecular pathogenesis of the Marfan syndrome. Cell M ol Life Sci 2001; 58: 1698-1707.

Germain DP. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg 2002; 16: 391-397.

Mao JR , Bristow J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest 2001; 107: 1063-1069.

Spittell JA , Beckman JA. Clinical pathologic conference. Vasc Med 2003; 8: 53-57.

Cohen MG , Anderson RD , Navia D , Belloso W , Gallo A , Grinfeld LR. Syphilitic aortitis. Catheter Cardiovasc Interv 2001; 52: 237-239.

Allins AD , Wagner WH , Cossman DV , Gold RN , Hiatt JR. Tuberculous infection of the descending thoracic and abdominal aorta: case report and literature review. Ann Vasc Surg 1999; 13: 439-444.

Roldan CA , Chavez J , Wiest PW , Qualls CR , Crawford MH. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 1998; 32: 1397-1404.

Cho KH , Kim YG , Yang SG , Lee DY , Chung JH. inflammatory nodules of the lower legs: a clinical and histological analysis of 134 cases in Korea. J Dermatol 1997; 24: 522-529.

Maeda S , Murao S , Sugiyama T , Utaka I , Okamoto R. Generalized sarcoidosis with ‘sarcoid aortitis’. Acta Pathol Jpn 1983; 33: 183-188.

Amor B. Reiter’s syndrome. Diagnosis and clinical features. Rheum Dis Clin North Am 1998; 24: 677-695, vii-vii.

Cosh JA , Barritt DW , Jayson MI. Cardiac lesions of Reiter’s syndrome and ankylosing spondylitis. Br Heart J 1973; 35: 553-553.

Letko E , Zafirakis P , Baltatzis S , Voudouri A , Livir-Rallatos C , Foster CS. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 2002; 31: 384-395.

Gaubitz M , Lubben B , Seidel M , Schotte H , Gramley F , Domschke W. Cogan’s syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol 2001; 19: 463-469.

St Clair EW , McCallum RM. Cogan’s syndrome. Curr Opin Rheumatol 1999; 11: 47-52.

Kerr GS , Hallahan CW , Giordano J et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919-929.

Castellote E , Romero R , Bonet J , Torguet P , Callejas JM , Caralps A. Takayasu’s arteritis as a cause of renovascular hypertension in a non-Asian population. J Hum Hypertens 1995; 9: 841-845.

Eichhorn J , Sima D , Thiele B et al. Anti-endothelial cell antibodies in Takayasu arteritis. Circulation 1996; 94: 2396-2401.

Talwar KK , Chopra P , Narula J et al. Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu’s disease)-a study by endomyocardial biopsy. Int J Cardiol 1988; 21: 323-334.

Talwar KK , Kumar K , Chopra P et al. Cardiac involvement in nonspecific aortoarteritis (Takayasu’s arteritis). Am Heart J 1991; 122: 1666-1670.

Sakane T , Takeno M , Suzuki N , Inaba G. Behcet’s disease. N Engl J Med 1999; 341: 1284-1291.

Lee SH , Chung KY , Lee WS , Lee S. Behcet’s syndrome associated with bullous necrotizing vasculitis. J Am Acad Dermatol 1989; 21: 327-330.

Dundar SV , Sivri B , Gokoz A. Vasculitis of breast in Behcet’s disease-a case report. Angiology 1988; 39: 921-924.

Gamble CN , Wiesner KB , Shapiro RF , Boyer WJ. The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behcet’s disease. Am J Med 1979; 66: 1031-1039.

Criteria for diagnosis of Behcet’s disease . International Study Group for Behcet’s Disease. Lancet 1990; 335: 1078-1080.

Higashihara M , Mori M , Takeuchi A , Ogita T , Miyamoto T , Okimoto T. Myocarditis in Behcet’s disease-a case report and review of the literature. J Rheumatol 1982; 9: 630-633.

El Ramahi KM , Al Dalaan A , Al Shaikh A , Al Meshari K , Akhtar M. Renal involvement in Behcet’s disease: review of 9 cases. J Rheumatol 1998; 25: 2254-2260.

Aksu K , Turgan N , Oksel F et al. Hyperhomocysteinaemia in Behcet’s disease. Rheumatology (Oxford) 2001; 40: 687-690.

Lee RG. The colitis of Behcet’s syndrome. Am J Surg Pathol 1986; 10: 888-893.

Chang HK , Cheon KS. The clinical significance of a pathergy reaction in patients with Behcet’s disease. J Korean M ed Sci 2002; 17: 371-374.

Ergun T , Gurbuz O , Harvell J , Jorizzo J , White W. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behcet’s disease. Int J Dermatol 1998; 37: 929-933.

Burmeister LA , Valdivia T , Nuttall FQ. Adult hereditary fructose intolerance. Arch Intern M ed 1991; 151: 773-776.

Cox TM. Hereditary fructose intolerance. Baillieres Clin Gastroenterol 1990; 4: 61-78.

Cross NC , Cox TM. Hereditary fructose intolerance. Int J Biochem 1990; 22: 685-689.

Watkins JB , Katz AJ , Grand RJ. Neonatal hepatitis: a diagnostic approach. Adv Pediatr 1977; 24: 399-454.

Lameire N , Mussche M , Baele G , Kint J , Ringoir S. Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med 1978; 65: 416-423.

Odievre M , Gentil C , Gautier M , Alagille D. Hereditary fructose intolerance in childhood. Diagnosis, management, and course in 55 patients. Am J Dis Child 1978; 132: 605-608.

Feigenbaum A. Description of Behcet’s syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol 1956; 40: 355-357.

Behcet H. Uber rezidivierende aphthose, durch ein Virus verursachte Geschwure am Mund, am Aug und an den Genitalien. Dermatol Wochenschr 1937; 36: 1152-1157.

Smith EL , Schur PH. Clinical manifestations and diagnosis of Behçet’s disease. In: UpToDate, Rose BD (ed), UpToDate, Wellesley, MA, 2004.

Yazici H , Yurdakul S , Hamuryudan V. Behcet disease. Curr Opin Rheumatol 2001; 13: 18-22.

O’Duffy JD. Behcet’s disease. Curr Opin Rheumatol 1994; 6: 39-43.

O’Duffy JD. Suggested criteria for diagnosisof Behçet’s disease. J Rheumatol 1974; 1 (suppl 1): 18-18 (abstract).

O’Neill TW , Rigby AS , Silman AJ , Barnes C. Validation of the International Study Group criteria for Behcet’s disease. Br J Rheumatol 1994; 33: 115-117.

Tunc R , Uluhan A , Melikoglu M , Ozyazgan Y , Ozdogan H , Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet’s syndrome. Clin Exp Rheumatol 2001; 19: S45-S47.

Ferraz MB , Walter SD , Heymann R , Atra E. Sensitivity and specificity of different diagnosticcriteria for Behcet’s disease according to the latent class approach. Br J Rheumatol 1995; 34: 932-935.

Golden BD , Goel A , Mitnick HJ. Behcet-type vasculopathy in a patient without the diagnostic features of Behcet’s disease. Arthritis Rheum 1996; 39: 1926-1930.

Smith EL , Schur PH. Treatment of Behçet’s disease. In: UpToDate, Rose BD (ed), UpToDate, Wellesley, MA, 2004.

Goossens PH , Verburg RJ , Breedveld FC. Remission of Behcet’s syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis 2001; 60: 637-637.

Sfikakis PP. Behcet’s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002; 61 (suppl 2): ii51-ii53.

Hamuryudan V , Mat C , Saip S et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:443-450.

Yasui K , Ohta K , Kobayashi M , Aizawa T , Komiyama A. Successful treatment of Behcet disease with pentoxifylline. Ann Intern M ed 1996; 124: 891-893.

Kural-Seyahi E , Fresko I , Seyahi N et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.